Atlas Trials

Study to Investigate the Treatment Benefits of Probiotic Streptococcus Salivarius K12 for Hospitalised Patients (Non-ICU) With COVID-19

Clinical trial NCT05043376 · COMPLETED

Trial details

NCT number
NCT05043376
Sponsor
King Edward Medical University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Covid19
Start date
2021-09-10
Primary completion
2021-11-21
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.